Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Advitech has announced that a second preclinical study conducted by Centre de Recherche du Centre Hospitalier de l'Universite Laval or CHUL provided new indications of the wound healing properties of a milk devired fraction originating from the research work on its XP828L and IM technological platforms.
Subscribe to our email newsletter
The new data reveals that Advitech’s fraction is capable of enhancing biochemical activity of fibroblasts (relative to cell proliferation and collagen synthesis) while preventing physiological phenomena that can result in excessive scaring.
This further confirms that this fraction, when used under specific conditions, acts early in the repair process by increasing the number of fibroblasts present in the wound, resulting in the production and deposition of collagen fibres present in the newly formed wound tissue.